183 related articles for article (PubMed ID: 35243423)
21. Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum.
Higuchi C; Tanihata Y; Nishimura H; Naito T; Sanaka T
Ther Apher Dial; 2005 Apr; 9(2):173-81. PubMed ID: 15828931
[TBL] [Abstract][Full Text] [Related]
22. PAI-1/PIAS3/Stat3/miR-34a forms a positive feedback loop to promote EMT-mediated metastasis through Stat3 signaling in Non-small cell lung cancer.
Lin X; Lin BW; Chen XL; Zhang BL; Xiao XJ; Shi JS; Lin JD; Chen X
Biochem Biophys Res Commun; 2017 Dec; 493(4):1464-1470. PubMed ID: 28988111
[TBL] [Abstract][Full Text] [Related]
23. Candidate host marker for peritoneal dissemination.
Hashizume K; Uchiyama A; Sasaki N; Noshiro H; Morisaki T; Tanaka M; Katano M
Anticancer Res; 2002; 22(3):1781-6. PubMed ID: 12168869
[TBL] [Abstract][Full Text] [Related]
24. Expression, Intracellular Localization, and Prognostic Value of Plasminogen Activator Inhibitor 1 and PAI-1 RNA-Binding Protein 1 in Primary and Recurrent Ovarian Cancer: A Study of the Tumor Bank Ovarian Cancer Network.
Koensgen D; Stope MB; Tuerbachova I; Bruennert D; Kohlmann T; Braicu I; Sehouli J; Denkert C; Darb-Esfahani S; Stickeler E; Sofroni D; Dahl E; Mustea A
Gynecol Obstet Invest; 2018; 83(5):508-514. PubMed ID: 28738361
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor-1 enhances radioresistance and aggressiveness of non-small cell lung cancer cells.
Kang J; Kim W; Kwon T; Youn H; Kim JS; Youn B
Oncotarget; 2016 Apr; 7(17):23961-74. PubMed ID: 27004408
[TBL] [Abstract][Full Text] [Related]
26. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors.
Chu DZ; Lang NP; Thompson C; Osteen PK; Westbrook KC
Cancer; 1989 Jan; 63(2):364-7. PubMed ID: 2910444
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal Stem Cells Engineered to Secrete Pigment Epithelium-Derived Factor Inhibit Tumor Metastasis and the Formation of Malignant Ascites in a Murine Colorectal Peritoneal Carcinomatosis Model.
Yang L; Zhang Y; Cheng L; Yue D; Ma J; Zhao D; Hou X; Xiang R; Cheng P
Hum Gene Ther; 2016 Mar; 27(3):267-77. PubMed ID: 26756933
[TBL] [Abstract][Full Text] [Related]
28. Simvastatin increases fibrinolytic activity in human peritoneal mesothelial cells independent of cholesterol lowering.
Haslinger B; Goedde MF; Toet KH; Kooistra T
Kidney Int; 2002 Nov; 62(5):1611-9. PubMed ID: 12371961
[TBL] [Abstract][Full Text] [Related]
29. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
[TBL] [Abstract][Full Text] [Related]
30. The effect of ascites, mass volume, and peritoneal carcinomatosis on serum CA125 levels in patients with ovarian carcinoma.
Saygili U; Guclu S; Uslu T; Erten O; Dogan E
Int J Gynecol Cancer; 2002; 12(5):438-42. PubMed ID: 12366659
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic Acid is a Biomarker for Peritoneal Carcinomatosis of Gastric Cancer and Correlates with Poor Prognosis.
Zeng R; Li B; Huang J; Zhong M; Li L; Duan C; Zeng S; Huang J; Liu W; Lu J; Tang Y; Zhou L; Liu Y; Li J; He Z; Wang Q; Dai Y
Genet Test Mol Biomarkers; 2017 Nov; 21(11):641-648. PubMed ID: 28910191
[TBL] [Abstract][Full Text] [Related]
32. Modulation of the expression of tissue plasminogen activator and its inhibitor by hypoxia in human peritoneal and adhesion fibroblasts.
Saed GM; Diamond MP
Fertil Steril; 2003 Jan; 79(1):164-8. PubMed ID: 12524082
[TBL] [Abstract][Full Text] [Related]
33. Malignant ascites: sonographic signs of peritoneal carcinomatosis.
Goerg C; Schwerk WB
Eur J Cancer; 1991; 27(6):720-3. PubMed ID: 1829911
[TBL] [Abstract][Full Text] [Related]
34. Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
Tempfer CB; Hilal Z; Dogan A; Petersen M; Rezniczek GA
Eur J Surg Oncol; 2018 Jul; 44(7):1112-1117. PubMed ID: 29753612
[TBL] [Abstract][Full Text] [Related]
35. Arctigenin alleviates TGF-β1-induced epithelial-mesenchymal transition and PAI-1 expression via AMPK/NF-κB pathway in peritoneal mesothelial cells.
Jin G; Su Y; Dong Q; Zhao X; Zhang L; Yan X
Biochem Biophys Res Commun; 2019 Dec; 520(2):413-419. PubMed ID: 31607474
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic vaccinia virus reinvigorates peritoneal immunity and cooperates with immune checkpoint inhibitor to suppress peritoneal carcinomatosis in colon cancer.
Lee YS; Lee WS; Kim CW; Lee SJ; Yang H; Kong SJ; Ning J; Yang KM; Kang B; Kim WR; Chon HJ; Kim C
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33199510
[TBL] [Abstract][Full Text] [Related]
37. The role of "closed abdomen" hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience.
Orgiano L; Pani F; Astara G; Madeddu C; Marini S; Manca A; Mantovani G
Support Care Cancer; 2016 Oct; 24(10):4293-9. PubMed ID: 27169699
[TBL] [Abstract][Full Text] [Related]
38. Simvastatin suppresses tissue factor expression and increases fibrinolytic activity in tumor necrosis factor-alpha-activated human peritoneal mesothelial cells.
Haslinger B; Kleemann R; Toet KH; Kooistra T
Kidney Int; 2003 Jun; 63(6):2065-74. PubMed ID: 12753293
[TBL] [Abstract][Full Text] [Related]
39. Is ascites CEA a risk factor for peritoneal carcinomatosis in colorectal cancer?: a long-term follow-up study.
Kim BC; Bae JH; Park SM; Won DY; Lee IK
Int J Colorectal Dis; 2020 Jan; 35(1):147-155. PubMed ID: 31802190
[TBL] [Abstract][Full Text] [Related]
40. STING activation normalizes the intraperitoneal vascular-immune microenvironment and suppresses peritoneal carcinomatosis of colon cancer.
Lee SJ; Yang H; Kim WR; Lee YS; Lee WS; Kong SJ; Lee HJ; Kim JH; Cheon J; Kang B; Chon HJ; Kim C
J Immunother Cancer; 2021 Jun; 9(6):. PubMed ID: 34145029
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
